(Q45102546)

9 December 2017

title

Endometrial effects of RU486 in primates--antiproliferative action despite signs of estrogen action and increased cyclin-B expression (English)

1 reference

9 December 2017

1 reference

Heikinheimo O

1

1 reference

9 December 2017

Hsiu JG

2

1 reference

9 December 2017

Gordon K

3

1 reference

9 December 2017

Kim S

4

1 reference

9 December 2017

Williams RF

5

1 reference

9 December 2017

Gibbons WE

6

1 reference

9 December 2017

Hodgen GD

7

1 reference

9 December 2017

publication date

1 October 1996

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

9 December 2017

published in

1 reference

9 December 2017

volume

59

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

179-190

1 reference

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Cyclins and their associated cyclin-dependent kinases in the human cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Arresting developments in cell-cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Molecular cloning, sequence analyses, and expression of complementary DNA encoding murine progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Molecular cloning and characterization of rat estrogen receptor cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Identification of a mouse B-type cyclin which exhibits developmentally regulated expression in the germ line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Estrogen and progestin receptors in the reproductive tract of male and female primates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Progestin inhibition of progesterone receptor gene expression in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Endometrial effects of long-term low-dose administration of RU486

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Regulation of the G2-mitosis transition

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Assessment of the potency of orally administered progestins in women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Treatment of breast cancer with different antiprogestins: preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2896%2900113-6

7 January 2021

10.1016/S0960-0760(96)00113-6

Identifiers

DOI

1 reference

9 December 2017

1 reference